Serine and metalloprotease signaling through PAR1 in arterial thrombosis and vascular injury

IUBMB Life

Volumn 63, Issue 6, 2011, Pages 412-418

  Koukos, Georgios ^a   Sevigny, Leila ^a,b   Zhang, Ping ^a   Covic, Lidija ^a,b   Kuliopulos, Athan ^a,b  

^a TUFTS MEDICAL CENTER   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

G protein mediated signaling; MMP 1; PAR1; platelet signaling; restenosis; serine proteases; thrombosis

Indexed keywords

ATOPAXAR; F 16618; GUANINE NUCLEOTIDE BINDING PROTEIN; INTERSTITIAL COLLAGENASE; METALLOPROTEINASE; PROTEINASE ACTIVATED RECEPTOR 1; RWJ 58259; SCH 79797; SERINE PROTEINASE; THROMBIN; THROMBIN RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG; VORAPAXAR;

ACUTE HEART INFARCTION; ANGIOPLASTY; ARTERY THROMBOSIS; BLEEDING; BLOOD VESSEL INJURY; CORONARY STENT; ENZYME ACTIVATION; ENZYME ACTIVE SITE; HOMEOSTASIS; HUMAN; NONHUMAN; PERCUTANEOUS CORONARY INTERVENTION; RECEPTOR AFFINITY; RESTENOSIS; REVIEW; SIGNAL TRANSDUCTION; THROMBOCYTE ACTIVATION;

ANIMALS; ARTERIES; ENZYME ACTIVATION; HUMANS; METALLOPROTEASES; RECEPTOR, PAR-1; SERINE PROTEASES; SIGNAL TRANSDUCTION; THROMBOSIS; VASCULAR SYSTEM INJURIES;

EID: 79959612780     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1002/iub.465     Document Type: Review

References (56)

1. Leger, A. J., Covic, L., and, Kuliopulos, A., (2006) Protease-activated receptors in cardiovascular diseases. Circulation 114, 1070-1077. (Pubitemid 44358884)
2. Jacques, S., LeMasurier, M., Sheridan, P. J., Seeley, S. K., and, Kuliopulos, A., (2000) Substrate-assisted catalysis of the PAR1 thrombin receptor: enhancement of macromolecular association and cleavage. J. Biol. Chem. 275, 40671-40678. (Pubitemid 32054883)
3. Seeley, S., Covic, L., Jacques, S. L., Sudmeier, J., Baleja, J. D., and, Kuliopulos, A., (2003) Structural basis for thrombin activation of a protease-activated receptor: inhibition of intramolecular liganding. Chem. Biol. 10, 1033-1041. (Pubitemid 37496433)
4. Swift, S., Xu, J., Trivedi, V., Austin, K. M., Tressel, S. L., Zhang, L., Covic, L., and, Kuliopulos, A., (2010) A novel protease-activated receptor-1 interactor, Bicaudal D1, regulates G protein signaling and internalization. J. Biol. Chem. 285, 11402-11410.
5. Ossovskaya, V. S., and, Bunnett, N. W., (2004) Protease-activated receptors: contribution to physiology and disease. Physiol. Rev. 84, 579-621. (Pubitemid 38365493)
6. Smyth, S. S., McEver, R. P., Weyrich, A. S., Morrell, C. N., Hoffman, M. R., Arepally, G. M., French, P. A., Dauerman, H. L., and, Becker, R.C., (2009) Platelet functions beyond hemostasis. J. Thromb. Haemost. 7, 1759-1766.
7. Vu, T.-K. H., Hung, D. T., Wheaton, V. I., and, Coughlin, S. R., (1991) Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor action. Cell 64, 1057-1068. (Pubitemid 121001193)
8. Nystedt, S., Emilsson, K., Wahlestedt, C., and, Sundelin, J., (1994) Molecular cloning of a potential proteinase activated receptor. Proc. Natl. Acad. Sci. USA 91, 9208-9212. (Pubitemid 24297883)
9. Nystedt, S., Ramakrishnan, V., and, Sundelin, J., (1996) The proteinase-activated receptor 2 is induced by inflammatory mediators in human endothelial cells. Comparison with the thrombin receptor. J. Biol. Chem. 271, 14910-14915. (Pubitemid 26197572)
10. Kuliopulos, A., Covic, L., Seeley, S. K., Sheridan, P. J., Helin, J., and, Costello, C. E., (1999) Plasmin desensitization of the PAR1 thrombin receptor: kinetics, sites of truncation, and implications for thrombolytic therapy. Biochemistry 38, 4572-4585.
11. Riewald, M., Petrovan, R. J., Donner, A., Mueller, B. M., and, Ruf, W., (2002) Activation of endothelial cell protease activated receptor 1 by the protein C pathway. Science 296, 1880-1882. (Pubitemid 34596276)
12. Parry, M. A. A., Myles, T., Tschopp, J., and, Stone, S. R., (1996) Cleavage of the thrombin receptor: identification of potential activators and inactivators. Biochem. J. 320, 335-341. (Pubitemid 26400199)
13. Camerer, E., Huang, W., and, Coughlin, S. R., (2000) Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa. Proc. Natl. Acad. Sci. USA 97, 5255-5260. (Pubitemid 30313705)
14. Camerer, E., Kataoka, H., Kahn, M., Lease, K., and, Coughlin, S. R., (2002) Genetic evidence that protease-activated receptors mediate factor Xa signaling in endothelial cells. J. Biol. Chem. 277, 16081-16087. (Pubitemid 34967893)
15. Molino, M., Blanchard, N., Belmonte, E., Tarver, A. P., Abrams, C., Hoxie, J. A., Cerletti, C., and, Brass, L. F., (1995) Proteolysis of the human platelet and endothelial cell thrombin receptor by neutrophil-derived cathepsin, G. J. Biol. Chem. 270, 11168-11175.
16. Schechter, N. M., Brass, L. F., Lavker, R. M., and, Jensen, P. J., (1998) Reaction of mast cell proteases tryptase and chymase with protease activated receptors (PARs) on keratinocytes and fibroblasts. J. Cell. Physiol. 176, 365-373. (Pubitemid 28319720)
17. Renesto, P., Si-Tahar, M., Moniatte, M., Balloy, V., van Dorsselaer, A., Pidard, D., and, Chignard, M., (1997) Specific inhibition of thrombin-induced cell activation by the neutrophil proteinases elastase, cathepsin G, and proteinase 3: evidence for distinct cleavage sites within the aminoterminal domain of the thrombin receptor. Blood 89, 1944-1953. (Pubitemid 27132109)
18. Boire, A., Covic, L., Agarwal, A., Jacques, S., Sherifi, S., and, Kuliopulos, A., (2005) PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells. Cell 120, 303-313. (Pubitemid 40222426)
19. Trivedi, V., Boire, A., Tchernychev, B., Kaneider, N. C., Leger, A. J., O'Callaghan, K., Covic, L., and, Kuliopulos, A., (2009) Platelet matrix metalloprotease-1 mediates thrombogenesis by activating PAR1 at a cryptic ligand site. Cell 137, 332-343.
20. Ludeman, M. J., Zheng, Y. W., Ishii, K., and, Coughlin, S. R., (2004) Regulated shedding of PAR1 N-terminal exodomain from endothelial cells. J. Biol. Chem. 279, 18592-18599. (Pubitemid 38623280)
21. Leger, A. J., Jacques, S. L., Badar, J., Kaneider, N. C., Derian, C. K., Andrade-Gordon, P., Covic, L., and, Kuliopulos, A., (2006) Blocking the protease-activated receptor 1-4 heterodimer in platelet-mediated thrombosis. Circulation 113, 1244-1254.
22. O'Brien, P. J., Prevost, N., Molino, M., Hollinger, M. K., Woolkalis, M. J., Woulfe, D. S., and, Brass, L. F., (2000) Thrombin responses in human endothelial cells. Contributions from receptors other than PAR1 include the transactivation of PAR2 by thrombin-cleaved PAR1. J. Biol. Chem. 275, 13502-13509. (Pubitemid 30257415)
23. Kaneider, N. C., Leger, A. J., Agarwal, A., Nguyen, N., Perides, G., Derian, C., Covic, L., and, Kuliopulos, A., (2007) "Role reversal" for the receptor PAR1 in sepsis-induced vascular damage. Nat. Immunol. 8, 1303-1312. (Pubitemid 350131169)
24. McLaughlin, J. N., Patterson, M. M., and, Malik, A. B., (2007) Protease-activated receptor-3 (PAR3) regulates PAR1 signaling by receptor dimerization. Proc. Natl. Acad. Sci. USA. 104, 5662-5667. (Pubitemid 47175737)
25. Rodriguez, D., Morrison, C. J., and, Overall, C. M., (2010) Matrix metalloproteinases: what do they not do? New substrates and biological roles identified by murine models and proteomics. Biochim. Biophys. Acta 1803, 39-54.
26. Agarwal, A., Covic, L., Sevigny, L. M., Kaneider, N. C., Lazarides, K., Azabdaftari, G., Sharifi, S., and, Kuliopulos, A., (2008) Targeting a metalloprotease-PAR1 signaling system with cell-penetrating pepducins inhibits angiogenesis, ascites, and progression of ovarian cancer. Mol. Cancer Ther. 7, 2746-2757.
27. Goerge, T., Barg, A., Schnaeker, E. M., Poppelmann, B., Shpacovitch, V., Rattenholl, A., Maaser, C., Luger, T. A., Steinhoff, M., and, Schneider, S. W., (2006) Tumor-derived matrix metalloproteinase-1 targets endothelial proteinase-activated receptor 1 promoting endothelial cell activation. Cancer Res. 66, 7766-7774. (Pubitemid 44289237)
28. Blackburn, J. S., and, Brinckerhoff, C. E., (2008) Matrix metalloproteinase-1 and thrombin differentially activate gene expression in endothelial cells via PAR-1 and promote angiogenesis. Am. J. Pathol. 173, 1736-1746.
29. Turk, B. E., Huang, L. L., Piro, E. T., and, Cantley, L. C., (2001) Determination of protease cleavage site motifs using mixture-based oriented peptide libraries. Nat. Biotech. 19, 661-667. (Pubitemid 32625438)
30. Netzel-Arnett, S., Fields, G. B., Birkedal-Hansen, H., Van Wart, H. E., and, Fields, G., (1991) Sequence specificities of human fibroblast and neutrophil collagenases [published erratum appears in J. Biol. Chem. 1991 Nov 5;266(31):21326]. J. Biol. Chem. 266, 6747-6755.
31. Yang, E., Boire, A., Agarwal, A., Nguyen, N., O'Callaghan, K., Tu, P., Kuliopulos, A., and, Covic, L., (2009) Blockade of PAR1 signaling with cell-penetrating pepducins inhibits Akt survival pathways in breast cancer cells and suppresses tumor survival and metastasis. Cancer Res. 69, 6223-6231.
32. Thim, T., Hagensen, M. K., Bentzon, J. F., and, Falk, E., (2008) From vulnerable plaque to atherothrombosis. J. Intern. Med. 263, 506-516. (Pubitemid 351545740)
33. Ruggeri, Z. M., (2002) Platelets in atherothrombosis. Nat. Med. 8, 1227-1234. (Pubitemid 35373553)
34. Dale, G. L., (2005) Coated-platelets: an emerging component of the procoagulant response. J. Thromb. Haemost. 3, 2185-2192. (Pubitemid 41727196)
35. Covic, L., Gresser, A. L., and, Kuliopulos, A., (2000) Biphasic kinetics of activation and signaling for PAR1 and PAR4 thrombin receptors in platelets. Biochemistry 39, 5458-5467. (Pubitemid 30257087)
36. Covic, L., Singh, C., Smith, H., and, Kuliopulos, A., (2002) Role of the PAR4 thrombin receptor in stabilizing platelet-platelet aggregates as revealed by a patient with Hermansky-Pudlak syndrome. Thromb. Haemost. 87, 722-727. (Pubitemid 34302962)
37. Gandhi, P. S., Chen, Z., and, Di Cera, E., (2010) Crystal structure of thrombin bound to the uncleaved extracellular fragment of PAR1. J. Biol. Chem. 285, 15393-15398.
38. Jacques, S. L., and, Kuliopulos, A., (2003) Protease-activated receptor-4 uses dual prolines and an anionic recognition motif for thrombin recognition and cleavage. Biochem. J. 376, 733-740. (Pubitemid 38058072)
39. Kimmelstiel, C., Zhang, P., Kapur, N. K., Weintraub, A., Krishnamurthy, B., Castaneda, V., Covic, L., and, Kuliopulos, A., (2011) Bivalirudin is a dual inhibitor of thrombin and collagen-dependent platelet activation in patients undergoing percutaneous coronary intervention. Circ. Cardiovasc. Interv., in press.
40. Mann, K. G., Whelihan, M. F., Butenas, S., and, Orfeo, T., (2007) Citrate anticoagulation and the dynamics of thrombin generation. J. Thromb. Haemost. 5, 2055-2061. (Pubitemid 47450024)
41. Gast, A., Tschopp, T. B., and, Baumgartner, H. R., (1994) Thrombin plays a key role in late platelet thrombus growth and/or stability. Effect of a specific thrombin inhibitor on thrombogenesis induced by aortic subendothelium exposed to flowing rabbit blood. Arterioscler. Thromb. 14, 1466-1474.
42. Inauen, W., Baumgartner, H. R., Bombeli, T., Haeberli, A., and, Straub, P. W., (1990) Dose- and shear rate-dependent effects of heparin on thrombogenesis induced by rabbit aorta subendothelium exposed to flowing human blood. Arteriosclerosis 10, 607-615. (Pubitemid 20220585)
43. Fressinaud, E., Sakariassen, K. S., Rothschild, C., Baumgartner, H. R., and, Meyer, D., (1992) Shear rate-dependent impairment of thrombus growth on collagen in nonanticoagulated blood from patients with von Willebrand disease and hemophilia, A. Blood 80, 988-994.
44. Okorie, U. M., Denney, W. S., Chatterjee, M. S., Neeves, K. B., and, Diamond, S. L., (2008) Determination of surface tissue factor thresholds that trigger coagulation at venous and arterial shear rates: amplification of 100 fM circulating tissue factor requires flow. Blood 111, 3507-3513.
45. Becker, R. C., Moliterno, D. J., Jennings, L. K., Pieper, K. S., Pei, J., Niederman, A., Ziada, K. M., Berman, G., Strony, J., Joseph, D., Mahaffey, K. W., Van de Werf, F., Veltri, E., and, Harrington, R. A., (2009) Safety and tolerability of SCH 530348 in patients undergoing non-urgent percutaneous coronary intervention: a randomised, double-blind, placebo-controlled phase II study. Lancet 373, 919-928.
46. Goto, S., Ogawa, H., Takeuchi, M., Flather, M. D., and, Bhatt, D. L., (2010) Double-blind, placebo-controlled Phase II studies of the protease-activated receptor 1 antagonist E5555 (atopaxar) in Japanese patients with acute coronary syndrome or high-risk coronary artery disease. Eur. Heart J. 31, 2601-2613.
47. Cheung, W. M., D'Andrea, M. R., Andrade-Gordon, P., and, Damiano, B. P., (1999) Altered vascular injury responses in mice deficient in protease-activated receptor-1. Arterioscler. Thromb. Vasc. Biol. 19, 3014-3024. (Pubitemid 30029832)
48. Takada, M., Tanaka, H., Yamada, T., Ito, O., Kogushi, M., Yanagimachi, M., Kawamura, T., Musha, T., Yoshida, F., Ito, M., Kobayashi, H., Yoshitake, S., and, Saito, I., (1998) Antibody to thrombin receptor inhibits neointimal smooth muscle cell accumulation without causing inhibition of platelet aggregation or altering hemostatic parameters after angioplasty in rat. Circ. Res. 82, 980-987. (Pubitemid 28225938)
49. Shi, Z. D., Ji, X. Y., Qazi, H., and, Tarbell, J. M., (2009) Interstitial flow promotes vascular fibroblast, myofibroblast, and smooth muscle cell motility in 3-D collagen I via upregulation of MMP-1. Am. J. Physiol. Heart Circ. Physiol. 297, H1225-1234.
50. Andrade-Gordon, P., Derian, C. K., Maryanoff, B. E., Zhang, H. C., Addo, M. F., Cheung, W., Damiano, B. P., D'Andrea, M. R., Darrow, A. L., de Garavilla, L., Eckardt, A. J., Giardino, E. C., Haertlein, B. J., and, McComsey, D. F., (2001) Administration of a potent antagonist of protease-activated receptor-1 (PAR-1) attenuates vascular restenosis following balloon angioplasty in rats. J. Pharmacol. Exp. Ther. 298, 34-42. (Pubitemid 32574507)
51. Chieng-Yane, P., Bocquet, A., Letienne, R., Bourbon, T., Sablayrolles, S., Perez, M., Hatem, S., Lompre, A. M., Le Grand, B., and, David-Dufilho, M., (2010) Protease activated Receptor-1 antagonist, F 16618 reduces arterial restenosis by down-regulation of TNF{alpha} and MMP7 expression, and migration and proliferation of vascular smooth muscle cells. J. Pharmacol. Exp. Ther., in press.
52. MacLeod, D. C., Strauss, B. H., de Jong, M., Escaned, J., Umans, V. A., van Suylen, R. J., Verkerk, A., de Feyter, P. J., and, Serruys, P. W., (1994) Proliferation and extracellular matrix synthesis of smooth muscle cells cultured from human coronary atherosclerotic and restenotic lesions. J. Am. Coll. Cardiol. 23, 59-65. (Pubitemid 24027192)
53. Sahara, M., Sata, M., Morita, T., Nakamura, K., Hirata, Y., and, Nagai, R., (2007) Diverse contribution of bone marrow-derived cells to vascular remodeling associated with pulmonary arterial hypertension and arterial neointimal formation. Circulation 115, 509-517. (Pubitemid 46184202)
54. Ho, I. A., Chan, K. Y., Ng, W. H., Guo, C. M., Hui, K. M., Cheang, P., and, Lam, P. Y., (2009) Matrix metalloproteinase 1 is necessary for the migration of human bone marrow-derived mesenchymal stem cells toward human glioma. Stem Cells 27, 1366-1375.
55. Huang, Y. L., Shi, G. Y., Lee, H., Jiang, M. J., Huang, B. M., Wu, H. L., and, Yang, H. Y., (2009) Thrombin induces nestin expression via the transactivation of EGFR signalings in rat vascular smooth muscle cells. Cell Signal 21, 954-968.
56. Chen, D., Abrahams, J. M., Smith, L. M., McVey, J. H., Lechler, R. I., and, Dorling, A., (2008) Regenerative repair after endoluminal injury in mice with specific antagonism of protease activated receptors on CD34+ vascular progenitors. Blood 111, 4155-4164.